Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2'-deoxyguanosine.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 298318)

Published in Proc Natl Acad Sci U S A on November 01, 1989

Authors

P M Price1, R Banerjee, G Acs

Author Affiliations

1: Department of Biochemistry, Mount Sinai School of Medicine, New York, NY 10029.

Articles citing this

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. Proc Natl Acad Sci U S A (1991) 3.82

Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob Agents Chemother (1997) 2.84

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 2.38

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66

Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil. Antimicrob Agents Chemother (1996) 1.42

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol (1994) 1.37

High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay. Antimicrob Agents Chemother (1993) 1.25

Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis. Antimicrob Agents Chemother (1991) 1.21

The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J Virol (1994) 1.08

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother (1994) 1.08

Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine. J Virol (1994) 0.95

Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus. Antimicrob Agents Chemother (2010) 0.89

Comparative inhibition of hepatitis B virus DNA polymerase and cellular DNA polymerases by triphosphates of sugar-modified 5-methyldeoxycytidines and of other nucleoside analogs. Antimicrob Agents Chemother (1991) 0.88

Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model. Antimicrob Agents Chemother (1992) 0.87

Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine. Antimicrob Agents Chemother (1995) 0.80

Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase. Antimicrob Agents Chemother (1998) 0.80

Articles cited by this

Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91

Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A (1972) 83.88

RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry (1977) 38.82

Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res (1985) 21.05

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet (1981) 13.54

A physical map of the DNA regions flanking the rabbit beta-globin gene. Cell (1977) 12.96

The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A (1987) 8.11

Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature (1979) 6.10

In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol (1986) 5.75

The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res (1983) 5.41

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell (1986) 5.35

Cloning and structural analyses of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res (1983) 4.94

Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc Natl Acad Sci U S A (1979) 4.71

Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (1979) 3.62

Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. Biochemistry (1987) 3.48

DNA polymerase in the core of the human hepatitis B virus candidate. J Virol (1974) 3.44

Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci U S A (1987) 3.05

Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03

Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46

Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol (1988) 2.11

In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother (1989) 1.90

Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology (1987) 1.45

An in vitro system for screening anti-hepatitis B virus drugs. Virology (1989) 1.44

Progress in the control of viral hepatitis: memorandum from a WHO meeting. Bull World Health Organ (1988) 1.14

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Ann Intern Med (1988) 1.11

Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial. Ann Intern Med (1987) 1.03

DNA cloned from the ayw subtype of hepatitis B virus. J Med Virol (1980) 1.00

Maintenance of woodchuck hepatitis virus activity in woodchuck hepatocyte primary culture. J Gen Virol (1987) 0.98

Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver (1985) 0.92

Approaches to the treatment of hepatitis B virus and delta-related liver disease. Semin Liver Dis (1986) 0.85

Articles by these authors

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A (1987) 8.11

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine. J Biol Chem (1982) 3.48

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol (1988) 3.21

ISOLATION OF ADENOSINE AMINO ACID ESTERS FROM A RIBONUCLEASE DIGEST OF SOLUBLE, LIVER RIBONUCLEIC ACID. Proc Natl Acad Sci U S A (1958) 2.61

The mechanisms of reovirus uncoating and gene activation in vivo. Virology (1972) 2.60

Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46

Asynchronous synthesis of the complementary strands of the reovirus genome. Proc Natl Acad Sci U S A (1971) 2.42

The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42

Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A (1982) 2.20

The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry (2000) 2.13

Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci U S A (1980) 2.08

How to obtain extreme multistability in coupled dynamical systems. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 1.97

Four base-specific nucleoside 5'-triphosphatases in the subviral core of reovirus. Nature (1970) 1.96

Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry (2004) 1.92

Protein initiation in eukaryotes: formation and function of a ternary complex composed of a partially purified ribosomal factor, methionyl transfer RNA, and guanosine triphosphate. Proc Natl Acad Sci U S A (1973) 1.83

Properties of RNA transcriptase in reovirus subviral particles. Proc Natl Acad Sci U S A (1970) 1.82

Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood (1988) 1.76

The reovirus replicative cycle: conservation of parental RNA and protein. Proc Natl Acad Sci U S A (1970) 1.76

AMINO ACID INCORPORATION IN PIGEON PANCREAS FRACTIONS. Proc Natl Acad Sci U S A (1958) 1.74

Evidence for heme-mediated redox regulation of human cystathionine beta-synthase activity. J Biol Chem (1998) 1.74

Studies of the interaction between Rad52 protein and the yeast single-stranded DNA binding protein RPA. Mol Cell Biol (1998) 1.74

The reovirus replicative cycle. Annu Rev Biochem (1976) 1.68

Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells. Biochim Biophys Acta (1974) 1.65

Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia (1988) 1.60

Correlation between hypomethylation of DNA and expression of globin genes in Friend erythroleukemia cells. Eur J Biochem (1977) 1.57

A novel mode of carbohydrate recognition in jacalin, a Moraceae plant lectin with a beta-prism fold. Nat Struct Biol (1996) 1.55

Protein synthesis initiation in eukaryotes. Characterization of ribosomal factors from mouse fibroblasts. J Biol Chem (1973) 1.53

Genomic structures and population histories of linguistically distinct tribal groups of India. Hum Genet (2001) 1.53

Characterization of NO binding to human cystathionine beta-synthase: possible implications of the effects of CO and NO binding to the human enzyme. J Inorg Biochem (2001) 1.53

Mechanism of reovirus double-stranded ribonucleic acid synthesis in vivo and in vitro. J Virol (1971) 1.47

Selective inhibition of ribosomal RNA synthesis in mammalian cells. Biochim Biophys Acta (1968) 1.45

Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem (2001) 1.42

Comparison of global transcription responses allows identification of Vibrio cholerae genes differentially expressed following infection. FEMS Microbiol Lett (2000) 1.42

Characterization of the heme and pyridoxal phosphate cofactors of human cystathionine beta-synthase reveals nonequivalent active sites. Biochemistry (1999) 1.33

Novel mixed-mode phase transition involving a composition-dependent displacive component. Phys Rev Lett (2011) 1.31

Hypomethylation of DNA during differentiation of Friend erythroleukemia cells. J Cell Biol (1980) 1.30

Assignment of enzymatic functions to specific regions of the PLP-dependent heme protein cystathionine beta-synthase. Biochemistry (1999) 1.29

Regulation of the reovirus RNA transcriptase by a viral capsomere protein. Virology (1972) 1.27

Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II. J Biol Chem (1997) 1.27

Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol (1988) 1.26

Targeted disruption of the methionine synthase gene in mice. Mol Cell Biol (2001) 1.26

Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Res (2001) 1.24

Evidence that cobalt-carbon bond homolysis is coupled to hydrogen atom abstraction from substrate in methylmalonyl-CoA mutase. Biochemistry (1997) 1.23

Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet (1996) 1.23

Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010. Infect Control Hosp Epidemiol (2012) 1.22

DNA sequence and analysis of human chromosome 9. Nature (2004) 1.21

Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol (2001) 1.21

Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM (1997) 1.19

Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses (1993) 1.17

NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol (2001) 1.16

The kinetics of conformational changes in hemoglobin, studied by laser photolysis. Proc Natl Acad Sci U S A (1974) 1.16

Formation of highly stable complexes between 5-azacytosine-substituted DNA and specific non-histone nuclear proteins. Implications for 5-azacytidine-mediated effects on DNA methylation and gene expression. J Biol Chem (1985) 1.16

Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. Lab Invest (1988) 1.15

Defects in human methionine synthase in cblG patients. Hum Mol Genet (1996) 1.15

Degradation of ribonucleic acid in mouse fibroblasts treated with actinomycin. J Cell Biol (1965) 1.14

The DNA sequence and comparative analysis of human chromosome 10. Nature (2004) 1.14

Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem (1999) 1.14

Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. J Control Release (2010) 1.13

Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med (1989) 1.13

Amino-terminal region of poliovirus 2C protein is sufficient for membrane binding. Virus Res (1998) 1.12

Paratesticular tumours. Br J Urol (1969) 1.11

Poliovirus-encoded protease 2APro cleaves the TATA-binding protein but does not inhibit host cell RNA polymerase II transcription in vitro. J Virol (1997) 1.10

Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. J Biomed Mater Res B Appl Biomater (2008) 1.09

Magnetic susceptibility measurements of deoxygenated hemoglobins and isolated chains. Biochim Biophys Acta (1975) 1.09

The effect of toyocamycin on cellular RNA synthesis. Biochim Biophys Acta (1969) 1.09

Thermodynamic and kinetic characterization of Co-C bond homolysis catalyzed by coenzyme B(12)-dependent methylmalonyl-CoA mutase. Biochemistry (2000) 1.09

Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells. Proc Natl Acad Sci U S A (1975) 1.08

Biochemical studies of the nucleoside analogue, formycin. J Biol Chem (1969) 1.07

The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine. Hepatology (1992) 1.07

Electron paramagnetic studies of nitric oxide haemoglobin derivatives: isolated subunits and nitric oxide hybrids. J Mol Biol (1973) 1.07

A substrate switch: a new mode of regulation in the methionine metabolic pathway. J Theor Biol (2000) 1.06

Chain initiation by reovirus RNA transcriptase in vitro. Nature (1970) 1.06

Visible absorption and electron spin resonance spectra of the isolated chains of human hemoglobin. Discussion of chain-mediated heme-heme interaction. Biochemistry (1969) 1.05

Characterization of RNA transcripts and virally coded proteins synthesized in mouse fibroblasts transfected with hepatitis B DNA: HBeAg synthesis in HBcAg-negative cells with active core-antigen genes. Biosci Rep (1983) 1.05

Negligible male gene flow across ethnic boundaries in India, revealed by analysis of Y-chromosomal DNA polymorphisms. Genome Res (1999) 1.05

Pyridoxal phosphate binding sites are similar in human heme-dependent and yeast heme-independent cystathionine beta-synthases. Evidence from 31P NMR and pulsed EPR spectroscopy that heme and PLP cofactors are not proximal in the human enzyme. J Biol Chem (2001) 1.04

Lymphatic vessel density is significantly increased in melanoma. J Cutan Pathol (2004) 1.03

Oxygen equilibria of human hemoglobin valency hybrids. Discussion on the intrinsic properties of alpha and beta chains in the native protein. J Mol Biol (1969) 1.02

A new method of preparing Ca2+-ATPase from sarcoplasmic reticulum: extraction with octylglucoside. Membr Biochem (1979) 1.01

Characterization of the heme in human cystathionine beta-synthase by X-ray absorption and electron paramagnetic resonance spectroscopies. Biochemistry (2000) 1.01

Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes. FEBS Lett (1989) 1.01

Artificial vitreous replacements. Biomed Mater Eng (2003) 1.01

Atomic scale structure and chemical composition across order-disorder interfaces. Phys Rev Lett (2009) 1.01

Biodegradable hybrid polymeric membranes for ocular drug delivery. Acta Biomater (2009) 1.00

Free radical scavenging, anti-glycation and tyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum. Bioresour Technol (2006) 0.99

Defects in auxiliary redox proteins lead to functional methionine synthase deficiency. J Biol Chem (1997) 0.98

Preparation and properties of the isolated alpha and beta chains of human hemoglobin in the ferri state. Investigation of oxidation-reduction equilibria. J Mol Biol (1969) 0.98

Coagulopathy secondary to vitamin K deficiency in hyperemesis gravidarum. Obstet Gynecol (1998) 0.98

Identification and characterization of an unusual double serine/threonine protein phosphatase 2C in the malaria parasite Plasmodium falciparum. J Biol Chem (1998) 0.98

Demonstration that mammalian methionine synthases are predominantly cobalamin-loaded. J Biol Chem (1995) 0.98

Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol (2001) 0.97

The logic of the hepatic methionine metabolic cycle. Biochim Biophys Acta (2009) 0.97

Role of the dimethylbenzimidazole tail in the reaction catalyzed by coenzyme B12-dependent methylmalonyl-CoA mutase. Biochemistry (1999) 0.97

Erythropoietin receptor contributes to melanoma cell survival in vivo. Oncogene (2011) 0.96

Resonance Raman characterization of the heme cofactor in cystathionine beta-synthase. Identification of the Fe-S(Cys) vibration in the six-coordinate low-spin heme. Biochemistry (2001) 0.96

Utilization of substrate analogs by mengovirus induced RNA polymerase. Virology (1969) 0.96